# Impact of Intravenous Iron Treatment of Preoperative Anemia in Patients With LEAD (IRONPAD)

> **NCT04083755** · PHASE4 · UNKNOWN · sponsor: **Biobizkaia Health Research Institute** · enrollment: 240 (estimated)

## Conditions studied

- Anemia
- Peripheral Arterial Occlusive Disease

## Interventions

- **DRUG:** Ferric Carboxymaltose Injection [Injectafer]
- **OTHER:** no treatment or oral iron supplementation

## Key facts

- **NCT ID:** NCT04083755
- **Lead sponsor:** Biobizkaia Health Research Institute
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-08-15
- **Primary completion:** 2025-06-30
- **Final completion:** 2025-12-31
- **Target enrollment:** 240 (ESTIMATED)
- **Last updated:** 2023-01-05

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04083755

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04083755, "Impact of Intravenous Iron Treatment of Preoperative Anemia in Patients With LEAD (IRONPAD)". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT04083755. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*